Your browser is no longer supported. Please, upgrade your browser.
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E42.11 EPS (ttm)2.87 Insider Own0.10% Shs Outstand1.34B Perf Week-2.28%
Market Cap158.71B Forward P/E19.19 EPS next Y6.29 Insider Trans-12.82% Shs Float1.34B Perf Month-6.92%
Income3.88B PEG3.10 EPS next Q1.29 Inst Own83.30% Short Float0.63% Perf Quarter-3.82%
Sales31.60B P/S5.02 EPS this Y-26.10% Inst Trans0.04% Short Ratio2.16 Perf Half Y-5.89%
Book/sh38.29 P/B3.15 EPS next Y10.19% ROA4.10% Target Price145.56 Perf Year9.62%
Cash/sh8.06 P/C14.98 EPS next 5Y13.57% ROE7.60% 52W Range98.94 - 135.89 Perf YTD3.06%
Dividend2.52 P/FCF59.51 EPS past 5Y0.80% ROI4.90% 52W High-11.16% Beta0.81
Dividend %2.09% Quick Ratio2.30 Sales past 5Y0.90% Gross Margin66.90% 52W Low22.01% ATR2.83
Employees90000 Current Ratio2.90 Sales Q/Q22.70% Oper. Margin13.80% RSI (14)36.64 Volatility1.82% 1.82%
OptionableYes Debt/Eq0.50 EPS Q/Q57.30% Profit Margin12.30% Rel Volume2.61 Prev Close127.75
ShortableYes LT Debt/Eq0.50 EarningsAug 24 BMO Payout82.20% Avg Volume3.93M Price120.72
Recom1.90 SMA20-4.60% SMA50-6.60% SMA200-2.79% Volume10,281,855 Change-5.50%
Jun-10-21Resumed Cowen Outperform $141
May-25-21Initiated Barclays Equal Weight $145
Apr-15-21Initiated Atlantic Equities Overweight $153
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $140
Dec-15-20Upgrade Goldman Sell → Neutral $100 → $119
Oct-08-20Upgrade Stifel Hold → Buy $125
Oct-08-20Upgrade Bernstein Mkt Perform → Outperform
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Oct-18-21 06:51PM  
05:48PM  
04:46PM  
02:29PM  
11:55AM  
06:56AM  
Oct-15-21 09:35AM  
08:49AM  
Oct-14-21 06:11PM  
09:04AM  
06:11AM  
Oct-13-21 07:18AM  
Oct-12-21 09:26AM  
09:10AM  
08:00AM  
Oct-11-21 01:30PM  
06:45AM  
Oct-08-21 12:07PM  
Oct-06-21 03:44PM  
Oct-04-21 10:00AM  
Oct-02-21 10:52AM  
Oct-01-21 06:46AM  
Sep-30-21 10:00AM  
Sep-29-21 11:01AM  
Sep-28-21 03:39PM  
10:15AM  
09:12AM  
02:00AM  
Sep-27-21 02:30AM  
02:30AM  
Sep-23-21 11:30AM  
09:59AM  
07:42AM  
Sep-22-21 03:29PM  
10:00AM  
Sep-20-21 02:59PM  
12:01PM  
06:36AM  
Sep-17-21 03:04PM  
07:24AM  
Sep-15-21 08:32AM  
Sep-13-21 05:29PM  
10:00AM  
09:57AM  
09:44AM  
Sep-08-21 07:01AM  
Sep-07-21 11:00AM  
08:00AM  
08:00AM  
Sep-06-21 12:17PM  
10:03AM  
Sep-04-21 10:55AM  
Sep-03-21 12:06PM  
Sep-02-21 01:34PM  
09:33AM  
Sep-01-21 02:16PM  
11:15AM  
Aug-30-21 04:41PM  
02:05PM  
09:57AM  
Aug-27-21 03:28PM  
12:09PM  
08:00AM  
08:00AM  
Aug-26-21 02:16PM  
Aug-25-21 04:54PM  
02:16PM  
09:26AM  
08:10AM  
Aug-24-21 04:05PM  
03:55PM  
03:00PM  
01:22PM  
11:58AM  
10:50AM  
10:47AM  
10:39AM  
09:15AM  
09:05AM  
08:13AM  
08:05AM  
07:17AM  
07:00AM  
07:00AM  
06:49AM  
06:45AM  
06:45AM  
04:59AM  
04:32AM  
03:56AM  
02:51AM  
Aug-23-21 02:27PM  
10:10AM  
09:18AM  
06:45AM  
Aug-22-21 04:31AM  
Aug-21-21 10:58AM  
Aug-20-21 01:36AM  
Aug-19-21 02:16PM  
12:10PM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lerman Bradley ESVP General Counsel & Corp SecSep 30Option Exercise78.0049,1473,833,46697,910Oct 01 06:13 PM
Lerman Bradley ESVP General Counsel & Corp SecSep 30Sale126.5849,1476,221,02748,763Oct 01 06:13 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 31Option Exercise74.8450,7753,800,00199,538Sep 01 05:27 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 31Sale134.1750,7756,812,48248,763Sep 01 05:27 PM
Martha GeoffreyCEOAug 25Option Exercise61.8111,581715,805105,936Aug 26 07:26 PM
Salmon SeanEVP & Pres Diabetes/CardiovascAug 25Option Exercise38.7128,4191,100,06654,458Aug 26 07:28 PM
Salmon SeanEVP & Pres Diabetes/CardiovascAug 25Sale134.0828,4193,810,49233,329Aug 26 07:28 PM
Martha GeoffreyCEOAug 25Sale132.6711,5811,536,45195,836Aug 26 07:26 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 02Sale131.524,000526,08048,194Aug 04 06:18 PM
Martha GeoffreyCEOJun 28Option Exercise55.3211,500636,18093,448Jun 30 06:21 PM
Martha GeoffreyCEOJun 28Sale125.2911,5001,440,83581,948Jun 30 06:21 PM
Wall Brett A.EVP & Pres NeuroscienceJun 21Sale123.5011514,20221,602Jun 22 05:58 PM
Wall Brett A.EVP & Pres NeuroscienceJun 18Option Exercise74.841,16887,41322,655Jun 22 05:58 PM
PARKHILL KAREN LEVP & Chief Financial OfficerJun 15Sale124.4760575,30486,223Jun 17 06:11 PM
Wall Brett A.EVP & Pres NeuroscienceJun 01Sale128.072,473316,71721,487Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Option Exercise82.7334,6562,866,92577,207Jun 01 05:55 PM
Wall Brett A.EVP & Pres NeuroscienceMay 28Option Exercise47.0012,300578,10031,315Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Sale126.6534,6564,389,18242,551Jun 01 05:55 PM
Martha GeoffreyCEOApr 05Option Exercise52.5011,712614,92591,246Apr 07 04:28 PM
Martha GeoffreyCEOApr 05Sale118.8311,7121,391,73781,938Apr 07 04:28 PM
PARKHILL KAREN LEVP & Chief Financial OfficerMar 15Sale119.1263275,28486,556Mar 16 05:19 PM
TEN HOEDT ROBEVP & President EMEAMar 02Option Exercise34.887,168250,02050,965Mar 03 05:23 PM
TEN HOEDT ROBEVP & President EMEAMar 02Sale117.987,168845,68143,797Mar 03 05:23 PM
Surface Carol ASVP, Chief HR OfficerDec 28Sale114.9015,0001,723,50034,150Dec 30 04:42 PM
Lerman Bradley ESVP General Counsel & Corp SecDec 22Sale115.562,605301,03451,543Dec 23 04:35 PM
WHITE ROBERT JOHNEVP & Pres. Medical SurgicalDec 18Sale115.4610,9301,261,97844,922Dec 21 05:06 PM
PARKHILL KAREN LEVP & Chief Financial OfficerDec 15Sale114.3367076,60186,897Dec 16 05:34 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Option Exercise62.7620,7151,300,07374,863Nov 10 05:18 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Sale113.1320,7152,343,48854,148Nov 10 05:18 PM